Skip to main content

Tomàs Pumarola Suñé

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca

Tomàs Pumarola Suñé

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca

Projects

Synthetic diagnostic device to substitute animal erythrocytes in classical haemagglutination assays: application to influenza virus surveillance.

IP: Eva Baldrich Rubio
Collaborators: Romina Dieli Crimi, Mónica Martínez Gallo, Andres Antón Pagarolas, Tomàs Pumarola Suñé, Cristina Andrés Vergés
Funding agency: Instituto de Salud Carlos III
Funding: 104500
Reference: DTS20/00093
Duration: 01/01/2021 - 30/06/2023

Eritrocitos sintéticos para la vigilancia del virus de la gripe

IP: Eva Baldrich Rubio
Collaborators: Andres Antón Pagarolas, José Raul Herance Camacho, Tomàs Pumarola Suñé, Cristina Andrés Vergés
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 100000
Reference: IU68-017255
Duration: 23/07/2020 - 22/04/2022

Virus Respiratorio Sincitial (VRS). Estudio de las características del virus, del huésped, y los factores ambientales como determinantes de la epidemia y su gravedad clínica.

IP: Tomàs Pumarola Suñé
Collaborators: M Teresa Martin Gomez, Blanca Borras Bermejo, Andres Antón Pagarolas, Carlos Rodrigo Gonzalo de Liria, Jorgina Vila Soler, Jesus Trejo Zahinos
Funding agency: Instituto de Salud Carlos III
Funding: 93170
Reference: PI18/00685
Duration: 01/01/2019 - 31/10/2022

Grups de recerca en Microbiologia Clínica de l'Hospital Universtari Vall d'Hebron

IP: Tomàs Pumarola Suñé
Collaborators: -
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2017SGR00906
Duration: 01/01/2017 - 31/12/2020

Related news

The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

Related professionals

David Moreno Martinez

David Moreno Martinez

Systemic Diseases
Read more
Raquel Ibarz Lopez

Raquel Ibarz Lopez

Administration and Management
Psychiatry, Mental Health and Addictions
Read more
Marina Muñoz López

Marina Muñoz López

Kidney Physiopathology
Read more
Gerard Orriols Torras

Gerard Orriols Torras

Research technician
Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.